Q4 2025 Guardian Pharmacy Services Inc Earnings Call Transcript
Key Points
- Guardian Pharmacy Services Inc (GRDN) reported a strong financial performance for 2025, with organic revenue growth of 13% and overall revenue growth of 18% due to acquisitions.
- Adjusted EBITDA grew by 27% year-over-year, with margins expanding by 50 basis points to 7.9%, demonstrating effective cost management and operational efficiency.
- The company successfully integrated acquisitions and expanded its operational footprint, particularly in the Pacific Northwest, contributing to its growth.
- Guardian's vaccine clinics administered over 120,000 vaccines, resulting in a 9% increase in script volumes and improved profitability.
- The company increased its cash balance by approximately $60 million, highlighting its strong cash-generating capabilities and financial flexibility.
- The introduction of the IRA has created operational complexities and pricing challenges, impacting the long-term care pharmacy ecosystem.
- Guardian Pharmacy Services Inc (GRDN) faces pressure from industry changes, including consolidation at the facility level and increasing operational complexity.
- The company is navigating the unintended consequences of the American Rescue Plan, which has created headwinds in the branded inhaler category.
- Despite strong performance, the integration of new acquisitions has dampened overall margins by approximately 90 basis points.
- The company anticipates a $65 million revenue headwind in 2027 due to additional branded drug negotiations under the IRA.
Good afternoon, ladies and gentlemen, and welcome to the Guardian Pharmacy Services fourth-quarter earnings release conference call. (Operator Instructions) This call is being recorded on Wednesday, March 11, 2026.
And I would now like to turn the conference over to Ashley Stockton. Please go ahead.
Good afternoon. Thank you for participating in today's conference call. My name is Ashley Stockton, Vice President, Investor Relations for Guardian Pharmacy Services. I'm joined on today's call by Fred Burke, President and Chief Executive Officer; and David Morris, Chief Financial Officer. After the close today, Guardian posted its financial results for the quarter ended December 31, 2025.
A copy of the press release is available on the company's Investor Relations website. Please note that today's discussion will include certain forward-looking statements that reflect our current assumptions and expectations, including those related to our future financial performance
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

